WAIKOLOA, Hawaii — Patients with moderate to severe dry eye disease who were administered oral re-esterified omega-3 supplements showed positive visual outcomes, according to a speaker at Hawaiian Eye 2016. Frank A. Bucci Jr., MD , conducted a prospective, double-masked, multicenter, interventional trial that included 105 patients who were randomized to receive re-esterified oral omega-3 supplements or placebo. Fifty-one patients were placed in the placebo group, and 54 patients were placed in the treatment group.
VIDEO: Surgeon discusses management of ocular surface squamous neoplasia
WAIKOLOA, Hawaii — At Hawaiian Eye, Helen K. Wu, MD, highlights her talk on the diagnosis, treatment, and management of ocular surface squamous neoplasia.
RegeneRx Biopharmaceuticals announces completion of enrollment for Phase 2b/3 dry eye trial in U.S.
RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that its U.S. joint venture with G-treeBNT, ReGenTree LLC, has completed enrollment of its Phase 2b/3 dr…
Brain’s natural plasticity could compensate for inner ear damage
Researchers from Massachusetts Eye and Ear/Harvard Medical School have described, for the first time, the adult brain’s ability to compensate for a near-complete loss of auditory nerve fibers that link the ear to the brain. The findings, published in t…
MyOptique Group Named a Bloomberg Business Innovator 2016
LONDON–(BUSINESS WIRE)–Bloomberg has unveiled its inaugural Bloomberg Business Innovators list, naming MyOptique Group as one of the breakthrough businesses disrupting the way people live, work and think in the UK.
Wet (Neovascular / Exudative) Macular Degeneration – Pipeline Review 2015 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/sj7g24/wet_neovascular) has announced the addition of the “Wet (Neovascular / Exudative) Macular Degeneration – Pipeline Review, H2 2015” report to their offering…